Understand the source comparison
TB-4 vs TB-500: The Distinction That Actually Matters
The naming issue that genuinely affects research outcomes isn't TB-4 versus TB4. It's distinguishing full-length Thymosin Beta-4 from TB-500, the synthetic fragment. TB-500 contains only the 7-amino-acid active region (Ac-LKKTETQ) responsible for actin binding
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The naming issue that genuinely affects research outcomes isn't TB-4 versus TB4. It's distinguishing full-length Thymosin Beta-4 from TB-500, the synthetic fragment. TB-500 contains only the 7-amino-acid active region (Ac-LKKTETQ) responsible for actin binding and cellular migration, making it cheaper to synthesize and more stable in solution. Full-length TB-4 includes 36 additional amino acids that modulate immune response, reduce oxidative stress, and influence endothelial cell differentiation. Functions the fragment doesn't replicate.
- In published research, full-length TB-4 demonstrated superior angiogenic effects in myocardial infarction models compared to TB-500. A 2010 study in Circulation Research found TB-4 increased capillary density by 62% versus 41% for the fragment at equivalent molar doses. The fragment works faster for localized wound healing (peak effect at 48–72 hours versus 5–7 days for full-length), but full-length TB-4 produces more durable tissue remodeling over 2–4 weeks. Researchers selecting between them should match peptide structure to experimental timeline and target mechanism.
- Here's the honest answer: most suppliers selling 'TB-4' or 'TB4' are actually shipping TB-500. The fragment. Because it's 60–70% cheaper to produce and generates similar short-term wound healing effects in animal models. Unless the product specification explicitly states '43-amino-acid full-length Thymosin Beta-4' and the certificate of analysis shows a molecular weight of approximately 4963 Da (not 858 Da for TB-500), assume you're receiving the fragment regardless of label nomenclature. This isn't fraud. It's industry convention. But it matters when replicating published studies that used authentic full-length TB-4.